Quinoline type mevalonolactones useful for treating hyperlipidemia,
hyperlipoproteinemia or atherosclerosis
    14.
    发明授权
    Quinoline type mevalonolactones useful for treating hyperlipidemia, hyperlipoproteinemia or atherosclerosis 失效
    可用于治疗高脂血症,高脂蛋白血症或动脉粥样硬化的喹啉型甲羟戊酸

    公开(公告)号:US5185328A

    公开(公告)日:1993-02-09

    申请号:US483829

    申请日:1990-02-23

    摘要: A compound of the formula: ##STR1## wherein R.sup.1, R.sup.2, R.sup.3, R.sup.4 and R.sup.6 are independently hydrogen, C.sub.1-6 alkyl, C.sub.1-6 cycloalkyl, C.sub.1-3 alkoxy, n-butoxy, i-butoxy, sec-butoxy, R.sup.7 R.sup.8 N-- (wherein R.sup.7 and R.sup.8 are independently hydrogen or C.sub.1-3 alkyl), trifluoromethyl, trifluoromethoxy, difluoromethoxy, fluoro, chloro, bromo, phenyl, phenoxy, benzyloxy, hydroxy, trimethylsilyloxy, diphenyl-t-butylsilyloxy, hydroxymethyl or --O(CH.sub.2).sub.l OR.sup.19 (wherein R.sup.19 is hydrogen or C.sub.1-3 alkyl, and l is 1,2 or 3); or when located at the ortho position to each other, R.sup.1 and R.sup.2, or R.sup.3 and R.sup.4 together form --CH.dbd.CH--CH.dbd.CH--; or when located at the ortho position to each other, R.sup.1 and R.sup.2 together form --OC(R.sup.15 l) (R.sup.16)O-- (wherein R.sup.15 and R.sup.16 are independently hydrogen or C.sub.1-3 alkyl); Y is --CH.sub.2 --, --CH.sub.2 CH.sub.2 --, --CH.dbd.CH--, --CH.sub.2 --CH.dbd.CH-- or -- CH.dbd.CH--CH.sub.2 --; and Z is --Q--CH.sub.2 WCH.sub.2 --CO.sub.2 R.sup.12, ##STR2## (wherein Q is --C(O)--, --C(OR.sup.13).sub.2 -- or --CH(OH)--; W is --C(O)--, --C(OR.sup.13).sub.2 -- or --C(R.sup.11) (OH)--; R.sup.11 is hydrogen atom or C.sub.1-3 alkyl; R.sup.12 is hydrogen or R.sup.14 (wherein R.sup.14 is physiologically hydrolyzable alkyl or M (wherein M is NH.sub.4, sodium, potassium, 1/2 calcium or a hydrate of lower alkyl amine, di-lower alkyl amine or tri-lower alkyl amine)); two R.sup.13 are independently primary or secondary C.sub.1-6 alkyl; or two R.sup.13 together form --(CH.sub.2).sub.2 -- or --(CH.sub.2).sub.3 ; R.sup.17 and R.sup.18 are independently hydrogen or C.sub.1-3 alkyl; and R.sup.5 is hydrogen, C.sub.1-6 alkyl, C.sub.2-3 alkenyl, C.sub.3-6 cycloalkyl, ##STR3## wherein R.sup.9 is a hydrogen atom, C.sub.1-4 alkyl, C.sub.1-3 alkoxy, fluoro, chloro, bromo or trifluoromethyl), phenyl--(CH.sub.2).sub.m -- (wherein m is 1,2 or 3), --(CH.sub.2).sub.n CH(CH.sub.3)--phenyl or phenyl--(CH.sub.2).sub.n CH(CH.sub.3)-- (wherein n is 0,1 or 2).

    摘要翻译: 下式的化合物:其中R 1,R 2,R 3,R 4和R 6独立地是氢,C 1-6烷基,C 1-6环烷基,C 1-3烷氧基,正丁氧基,异丁氧基,仲丁氧基, 丁氧基,R7R8N-(其中R7和R8独立地是氢或C1-3烷基),三氟甲基,三氟甲氧基,二氟甲氧基,氟,氯,溴,苯基,苯氧基,苄氧基,羟基,三甲基甲硅烷氧基,二苯基叔丁基甲硅烷氧基,羟甲基或 - O(CH 2)lOR 19(其中R 19是氢或C 1-3烷基,且l是1,2或3); 或当位于彼此的邻位时,R1和R2,或R3和R4一起形成-CH = CH-CH = CH-; 或当位于彼此的邻位时,R1和R2一起形成-OC(R151)(R16)O-(其中R15和R16独立地为氢或C1-3烷基); Y是-CH 2 - , - CH 2 CH 2 - , - CH = CH - , - CH 2 -CH = CH-或-CH = CH-CH 2 - ; (其中Q为-C(O) - , - C(OR 13)2 - 或-CH(OH) - ); W为-C(O) - (CH 2) ,-C(OR 13)2 - 或-C(R 11)(OH) - ; R 11为氢原子或C 1-3烷基; R 12为氢或R 14(其中R 14为生理上可水解的烷基或M(其中M为NH 4,钠 ,二价低级烷基胺或三低级烷基胺的水合物));两个R 13独立地为伯或仲C 1-6烷基;或两个R 13一起形成 - (CH 2) 2-或 - (CH 2)3; R 17和R 18独立地是氢或C 1-3烷基; R 5是氢,C 1-6烷基,C 2-3烯基,C 3-6环烷基,其中R 9是氢原子 ,C 1-4烷基,C 1-3烷氧基,氟,氯,溴或三氟甲基),苯基 - (CH 2)m - (其中m为1,2或3), - (CH 2)n CH(CH 3) - (CH 2)n CH(CH 3) - (其中n为0,1或2)。

    SPEAKER RETENTION BRACKET AND METHOD
    20.
    发明申请
    SPEAKER RETENTION BRACKET AND METHOD 有权
    扬声器保持支架和方法

    公开(公告)号:US20080310668A1

    公开(公告)日:2008-12-18

    申请号:US11763774

    申请日:2007-06-15

    IPC分类号: H04R1/02

    摘要: An audio speaker bracket for use in passenger vehicles and a method for installing the speaker to a mounting panel using at feast one suspension member. The method permits the speaker to be temporarily supported by a mounting panel while secure attachment of the bracket to the mounting panel is completed.

    摘要翻译: 用于乘客车辆的音频扬声器支架以及使用一个悬挂构件将扬声器安装到安装面板的方法。 该方法允许扬声器由安装面板临时支撑,同时完成将支架固定到安装面板上。